ARCHIVES

Efaproxyn Improved Survival Of Patients With Brain Mets

This article is from The Cancer Letter archive.

Vol. 27 No. 10 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Pitot Supports Clearinghouse Modifications

January 20, 1978

NCI Bypass Budget Request For FY 1982Seeks $1.192 Billion; Would Fund 40% Of Competing R01s

May 23, 1980

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

February 22, 2013

NCI Would Fund 1,052 Competing Grants In Fy95

February 11, 1994

Tykerb Plus Letrozole Delayed Metastatic Breast Cancer

January 30, 2009